ORKA Oruka Therapeutics, Inc.

NEUTRAL Impact: 3/10 Insider Cluster (3 insiders)
Horizon days Filed May 22, 2026 Processed 18d 11h ago
Insider cluster: 2 insiders, $540K total
Latest settled — T+5d
ORKA ▼ -6.48% at T+5d
NEUTRAL call ✗ call lost -6.48% · α vs SPY -7.70% · entry $59.06 → $55.23
Next anchor: T+20d in 13d
Last close $64.06 (close Jun 8) · +8.47% from $59.06 entry
Entry anchored
May 22, 2026
via day open
T+1d
-1.81%
call -1.81% · α -1.82%
$57.99
settled 15d ago
T+5d
-6.48%
call -6.48% · α -7.70%
$55.23
settled 9d ago
T+20d
call — · α —
in 13d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Director Carl Dambkowski and SVP Arjun Agarwal executed derivative exercises and open-market sales, with total open-market sales of ~$2.78M on the cluster window. The sales are modest relative to ORKA's $3.5B market cap (~0.08%) and are tied to derivative exercise/cashless exercise-and-sell patterns — a routine liquidity mechanism rather than informed selling.

Key Financial Metrics

Direction
selling
Total Value
$2.8M
Insiders
3

Actionable Insight

No actionable signal. The cluster consists entirely of derivative-exercise-and-sell transactions by two insiders — a standard pattern for tax withholding and cashless exercise. With CMO Joana Goncalves also selling a smaller lot, there is no evidence of coordinated bearish conviction. Historical calibration shows ORKA insider cluster reports have been unreliable, with the model's T+20 average alpha at -0.96% in this segment. Ignore this cluster.

Key Facts

  • Director Carl Dambkowski sold 38,318 shares on 2026-05-21 at ~$58.43 for ~$2.24M, combined with derivative exercises (38,689 shares at $6.84 and 11,904 shares at $0).
  • SVP Arjun Agarwal sold 4,190 shares on 2026-05-18 at ~$58.34 for ~$244K, combined with derivative exercises (2,000 shares at $12.50 and 2,000 shares at $0).
  • Total open-market sales: ~$2.78M, representing ~0.08% of ORKA's $3.5B market cap.
  • CMO Joana Goncalves sold 4.8K shares at ~$61.56 for ~$295K in the 7d window — an additional partial cluster participant.
  • All sales in the cluster are derivative-related, not outright open-market portfolio liquidation.

Financial Impact

Total insider sale value of ~$2.78M is trivial relative to $3.5B market cap (~0.08%) — noise floor.

insider holdings reductiondilution from derivative exercises

Risk Factors

  • If the company is in a pre-approval or data-readout window, any insider sale gets outsized attention — manage headline risk.
  • Non-open-market exercises (A, M, F) do not reflect bearish conviction but are often mischaracterized by retail media.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ORKA-1779483291571
12 reports for ORKA
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+20▲ +20.18%Apr 27, 2026
Filters
Rows
Reports for ORKA — sortable, filterable
Type Now
Jun 1, 2026
8d ago
8-K
BULLISH ★ 7/10
$55.23 $57.20▲ +3.57%▲ +4.26%$64.06 (+15.99%)
May 22, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$59.06 $57.99▼ −1.81%▼ −1.82%$64.06 (+8.47%)
May 18, 2026
22d ago
Insider Cluster
NEUTRAL ★ 3/10
$57.50 $60.67▲ +5.51%▲ +4.47%$64.06 (+11.41%)
Apr 28, 2026
6w ago
Press Release
BEARISH ★ 6/10
$68.10 $68.10· 0.00%▲ +1.02%$64.06 (+5.93%)
Apr 27, 2026
6w ago
424B5
BEARISH ★ 7/10
$73.99 $69.49▲ +6.08%▲ +6.07%$64.06 (+13.42%)
Apr 27, 2026
6w ago
Press Release
BEARISH ★ 6/10
$73.99 $69.49▲ +6.08%▲ +6.07%$64.06 (+13.42%)
Apr 27, 2026
6w ago
8-K
BULLISH ★ 8/10
$76.39 $73.99▼ −3.14%▼ −2.66%$64.06 (−16.14%)
Apr 17, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$68.87 $69.00▲ +0.19%▲ +0.84%$64.06 (−6.98%)
Apr 15, 2026
7w ago
144
NEUTRAL ★ 3/10
$67.07 $68.92▲ +2.76%▲ +1.54%$64.06 (−4.49%)
Apr 13, 2026
8w ago
EFFECT
NEUTRAL ★ 3/10
$61.38 $67.06▲ +9.25%▲ +8.04%$64.06 (+4.37%)
Showing 10 of 12

US Market Status

Market Closed — Opens in 5h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access